Pericentral activity of alpha-fetoprotein enhancer 3 and glutamine synthetase upstream enhancer in the adult liver are regulated by β-catenin in mice

Hepatology

Volumn 56, Issue 5, 2012, Pages 1892-1901

  Clinkenbeard, Erica L ^a   Butler, James E ^a   Spear, Brett T ^a,b  

^a Department of Microbiology Immunology and Molecular Genetics ^*  (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; ALPHA FETOPROTEIN ENHANCER 3; BETA CATENIN; GLUTAMATE AMMONIA LIGASE; LYMPHOID ENHANCER FACTOR 1; MESSENGER RNA; T CELL FACTOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; LIVER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RAT; T LYMPHOCYTE;

ALPHA-FETOPROTEINS; ANIMALS; BETA CATENIN; CELL LINE, TUMOR; ENHANCER ELEMENTS, GENETIC; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GLUTAMATE-AMMONIA LIGASE; LIVER; MICE; MICE, TRANSGENIC; RATS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TCF TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 84868249469     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.25819     Document Type: Article

References (48)

1. Gebhardt R. Metabolic zonation of the liver: regulation and implications for liver function. Pharmacol Ther 1992; 53: 275-354.
2. Spear BT, Jin L, Ramasamy S, Dobierzewska A. Transcriptional control in the mammalian liver: liver development, perinatal repression, and zonal gene regulation. Cell Mol Life Sci 2006; 63: 2922-2938.
3. Jungermann K, Katz N. Functional specialization of different hepatocyte subpopulations. Physiol Rev 1989; 69: 708-763.
4. Gebhardt R, Mecke D. Heterogenous distribution of glutamine synthetase among rat liver parenchymal cells in situ and in primary culture. EMBO J 1983; 2: 5678-5700.
5. Jungermann K, Kietzmann T. Zonation of parenchymal and nonparenchymal metabolism in the liver. Annu Rev Nutr 1996; 16: 179-203.
6. Jungermann K, Kietzmann T. Oxygen: modulator of metabolic zonation and disease of the liver. HEPATOLOGY 2000; 31: 255-260.
7. Benhamouche S, Decaens T, Godard C, Chambrey R, Rickman DS, Moinard C, et al. Apc tumor suppressor gene is the "zonation-keeper" of mouse liver. Dev Cell 2006; 10: 759-770.
8. Cadoret A, Ovejero C, Terris B, Souil E, Levy L, Lamers WH, et al. New targets of beta-catenin signaling in the liver are involved in the glutamine metabolism. Oncogene 2002; 21: 8293-8301.
9. Hailfinger S, Jaworski M, Braeuning A, Buchmann A, Schwarz M. Zonal gene expression in murine liver: lessons from tumors. HEPATOLOGY 2006; 43: 407-414.
10. Behrens J, von Kries JP, Kuhl M, Bruhn L, Wedlich D, Grosschedl R, Birchmeier W. Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 1996; 382: 638-642.
11. Jennings BH, Ish-Horowicz D. The Groucho/TLE/Grg family of transcriptional co-repressors. Genome Biol 2008; 9: 205.
12. Sun Y, Kolligs FT, Hottiger MO, Mosavin R, Fearon ER, Nabel GJ. Regulation of beta-catenin transformation by the p300 transcriptional coactivator. Proc Natl Acad Sci U S A 2000; 97: 12613-12618.
13. Peyton DK, Ramesh T, Spear BT. Position-dependent activity of α-fetoprotein enhancer element III in the adult liver is due to negative regulation. Proc Nat Acad Sci U S A 2000; 97: 10890-10894.
14. Ramesh T, Ellis AW, Spear BT. Individual mouse α-fetoprotein enhancer elements exhibit different patterns of tissue-specific and hepatic position-dependent activity. Mol Cell Biol 1995; 15: 4947-4955.
15. Belayew A, Tilghman SM. Genetic analysis of α-fetoprotein synthesis in mice. Mol. Cell. Biol 1982; 2: 1427-1435.
16. Sarkar G, Sommer SS. The "megaprimer" method of site-directed mutagenesis. Biotechniques 1990; 8: 404-407.
17. Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, et al. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 1997; 275: 1784-1787.
18. Orford K, Crockett C, Jensen JP, Weissman AM, Byers SW. Serine phosphorylation-regulated ubiquitination and degradation of beta-catenin. J Biol Chem 1997; 272: 24735-24738.
19. Evans PM, Chen X, Zhang W, Liu C. KLF4 interacts with beta-catenin/TCF4 and blocks p300/CBP recruitment by beta-catenin. Mol Cell Biol 2010; 30: 372-381.
20. Spear BT, Tilghman SM. Role of α-fetoprotein regulatory elements in transcriptional activition in transient heterokaryons. Mol Cell Biol 1990; 10: 5047-5054.
21. Liu H, Ren H, Spear BT. The mouse alpha-albumin (afamin) promoter is differentially regulated by hepatocyte nuclear factor 1alpha and hepatocyte nuclear factor 1beta. DNA Cell Biol 2011; 30: 137-147.
22. Postic C, Magnuson MA. DNA excision in liver by an albumin-Cre transgene occurs progressively with age. Genesis 2000; 26: 149-150.
23. Brault V, Moore R, Kutsch S, Ishibashi M, Rowitch DH, McMahon AP, et al. Inactivation of the beta-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development. Development 2001; 128: 1253-1264.
24. Zhang G, Budker V, Wolff JA. High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum Gene Ther 1999; 10: 1735-1737.
25. Gebhardt R, Williams GM. Glutamine synthetase and hepatocarcinogenesis. Carcinogenesis 1995; 16: 1673-1681.
26. Fahrner J, Labruyere WT, Gaunitz C, Moorman AFM, Gebhardt R, Lamers WH. Identification and functional characterization of regulatory elements of the glutamine synthetase gene from rat liver. Eur J Biochem 1993; 213: 1067-1073.
27. Gaunitz F, Heise K, Gebhardt R. A silencer element in the first intron of the glutamine synthetase gene represses induction by glucocorticoids. Mol Endocrinol 2004; 18: 63-69.
28. Gaunitz F, Weber S, Scheja L, Gebhardt R. Identification of a cis-acting element and a novel trans-acting factor of the glutamine synthetase gene in liver cells. Biochem Biophys Res Comm 2004; 284: 377-383.
29. Garcia de Veas Lovillo RM, Ruijter JM, Labruyere WT, Hakvoort TB, Lamers WH. Upstream and intronic regulatory sequences interact in the activation of the glutamine synthetase promoter. Eur J Biochem 2003; 270: 206-212.
30. Lie-Venema H, de Boer PA, Moorman AF, Lamers WH. Organ-specific activity of the 5′ regulatory region of the glutamine synthetase gene in developing mice. Eur J Biochem 1997; 248: 644-659.
31. Lie-Venema H, Labruyere WT, van Roon MA, de Boer PA, Moorman AF, Berns AJ, Lamers WH. The spatio-temporal control of the expression of glutamine synthetase in the liver is mediated by its 5′-enhancer. J Biol Chem 1995; 270: 28251-28256.
32. Braeuning A, Singh Y, Rignall B, Buchmann A, Hammad S, Othman A, et al. Phenotype and growth behavior of residual beta-catenin-positive hepatocytes in livers of beta-catenin-deficient mice. Histochem Cell Biol 2010; 134: 469-481.
33. Werth M, Gebhardt R, Gaunitz F. Hepatic expression of glutamine synthetase in rats is controlled by STAT5 and TCF transcription factors. HEPATOLOGY 2006; 44: 967-975.
34. Jin L, Long L, Green MA, Spear BT. The alpha-fetoprotein enhancer region activates the albumin and alpha-fetoprotein promoters during liver development. Dev Biol 2009; 336: 294-300.
35. Sekiya T, Zaret KS. Repression by Groucho/TLE/Grg proteins: genomic site recruitment generates compacted chromatin in vitro and impairs activator binding in vivo. Mol Cell 2007; 28: 291-303.
36. Mallo M, Franco del Amo F, Gridley T. Cloning and developmental expression of Grg, a mouse gene related to the groucho transcript of the Drosophila Enhancer of split complex. Mech Dev 1993; 42: 67-76.
37. Miyasaka H, Choudhury BK, Hou EW, Li SS. Molecular cloning and expression of mouse and human cDNA encoding AES and ESG proteins with strong similarity to Drosophila enhancer of split groucho protein. Eur J Biochem 1993; 216: 343-352.
38. Godbout R, Ingram RS, Tilghman SM. Fine-structure mapping of the three mouse α-fetoprotein enhancers. Mol Cell Biol 1988; 8: 1169-1178.
39. Thomassin H, Bois-Joyeux B, Delille R, Ikonomova R, Danan J-L. Chicken ovalbumin upstream promoter-transcription factor, hepatocyte nuclear factor 3, an CCAAT/enhancer BINDING PROTEIN CONTROL THE FAR UPSTREAM ENHANCER OF THE RAT ALPHA-FETOPROTEIN Gene. DNA Cell Biol 1996; 15: 1063-1074.
40. Bois-Joyeuz B, Chauvet C, Nacer-Cherif H, Bergeret W, Mazure N, Giguere V, et al. Modulation of the far-upstream enhancer of the rat α-fetoprotein gene by members of the RORα, Rev-erbα, and rev-erbβ groups of monomeric orphan nuclear receptors. DNA Cell Biol 2000; 19: 589-599.
41. Stanulovic VS, Kyrmizi I, Kruithof-de Julio M, Hoogenkamp M, Vermeulen JL, Ruijter JM, et al. Hepatic HNF4alpha deficiency induces periportal expression of glutamine synthetase and other pericentral enzymes. HEPATOLOGY. 2007; 45: 433-444.
42. Colletti M, Cicchini C, Conigliaro A, Santangelo L, Alonzi T, Pasquini E, et al. Convergence of Wnt signaling on the HNF4alpha-driven transcription in controlling liver zonation. Gastroenterology 2009; 137: 660-672.
43. Tan X, Yuan Y, Zeng G, Apte U, Thompson MD, Cieply B, et al. Beta-catenin deletion in hepatoblasts disrupts hepatic morphogenesis and survival during mouse development. HEPATOLOGY 2008; 47: 1667-1679.
44. Peng SY, Chen WJ, Lai PL, Jeng YM, Sheu JC, Hsu HC. High alpha-fetoprotein level correlates with high stage, early recurrence, and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53, and beta-catenin mutations. Int J Cancer 2004; 112: 44-50.
45. Torbenson M, Kannangai R, Abraham S, Sahin F, Choti M, Wang J. Concurrent evaluation of p53, beta-catenin, and alpha-fetoprotein expression in human hepatocellular carcinoma. Am J Clin Pathol 2004; 122: 377-382.
46. Gorog D, Regoly-Merei J, Paku S, Kopper L, Nagy P. Alpha-fetoprotein expression is a potential prognostic marker in hepatocellular carcinoma. World J Gastroenterol 2005; 11: 5015-5018.
47. Loeppen S, Schneider D, Gaunitz F, Gebhardt R, Kurek R, Buchmann A, Schwarz M. Overexpression of glutamine synthetase is associated with beta-catenin-mutations in mouse liver tumors during promotion of hepatocarcinogenesis by phenobarbital. Cancer Res 2002; 62: 5685-5688.
48. Emerson JA, Vacher J, Cirillo LA, Tilghman SM, Tyner AL. The zonal expression of α-fetoprotein transgenes in the livers of adult mice. Dev Dyn 1992; 195: 55-66.